Financial reports
10-Q
2022 Q2
Quarterly report
8 Aug 22
10-Q
2022 Q1
Quarterly report
10 May 22
10-K
2021 FY
Annual report
28 Feb 22
10-Q
2021 Q3
Quarterly report
9 Nov 21
10-Q
2021 Q2
Quarterly report
9 Aug 21
10-Q
2021 Q1
Quarterly report
5 May 21
10-K
2020 FY
Annual report
1 Mar 21
10-Q
2020 Q3
Quarterly report
12 Nov 20
10-Q
2020 Q2
Quarterly report
10 Aug 20
10-Q
2020 Q1
Quarterly report
12 May 20
Current reports
8-K
Termination of a Material Definitive Agreement
17 Aug 22
8-K
Turning Point Therapeutics Reports Second-quarter 2022 Financial Results, Provides Operational Updates
8 Aug 22
8-K
Entry into a Material Definitive Agreement
24 Jun 22
8-K
Submission of Matters to a Vote of Security Holders
21 Jun 22
8-K
Entry into a Material Definitive Agreement
3 Jun 22
8-K
Bristol Myers Squibb to Acquire Turning Point Therapeutics, a Leading Precision Oncology Company
3 Jun 22
8-K
Turning Point Therapeutics Reports First-quarter 2022 Financial Results, Provides Operational Updates
10 May 22
8-K
Entry into a Material Definitive Agreement
5 May 22
8-K
Other Events
13 Apr 22
8-K
Departure of Directors or Certain Officers
4 Mar 22
Registration and prospectus
15-12G
Securities registration termination
29 Aug 22
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Aug 22
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Aug 22
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Aug 22
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Aug 22
25-NSE
Exchange delisting
17 Aug 22
POS AM
Prospectus update (post-effective amendment)
17 Aug 22
SC 14D9/A
Tender offer solicitation (amended)
16 Aug 22
SC TO-T/A
Third party tender offer statement (amended)
16 Aug 22
SC 14D9/A
Tender offer solicitation (amended)
9 Aug 22
Proxies
DEFA14A
Additional proxy soliciting materials
29 Apr 22
DEF 14A
Definitive proxy
29 Apr 22
DEFA14A
Additional proxy soliciting materials
25 May 21
DEFA14A
Additional proxy soliciting materials
15 Apr 21
DEF 14A
Definitive proxy
15 Apr 21
DEFA14A
Additional proxy soliciting materials
29 Apr 20
DEF 14A
Definitive proxy
29 Apr 20
Other
EFFECT
Notice of effectiveness
23 Aug 22
EFFECT
Notice of effectiveness
6 Sep 19
CORRESP
Correspondence with SEC
3 Sep 19
CORRESP
Correspondence with SEC
3 Sep 19
UPLOAD
Letter from SEC
23 Aug 19
EFFECT
Notice of effectiveness
17 Apr 19
CERT
Certification of approval for exchange listing
16 Apr 19
CORRESP
Correspondence with SEC
15 Apr 19
CORRESP
Correspondence with SEC
15 Apr 19
CORRESP
Correspondence with SEC
11 Apr 19